CREB1 and breast carcinoma: In another paper, inhibition of multidrug resistance 1 expression has been shown to reverse doxorubicin resistance in the drug-resistant breast cancer cell line MCF-7/adr through activation of the AMPK-GSK-3β-CREB pathway (Tran et al, 2013).